Cargando…

Angiogenesis and arthritis: a potential therapeutic target?

Detalles Bibliográficos
Autores principales:	Grosjean, J, Sivakumar, B, Paleolog, E
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833486/ http://dx.doi.org/10.1186/ar1356

Ejemplares similares

Angiogenesis in rheumatoid arthritis: the role of fut 1
por: Koch, Alisa Erika
Publicado: (2012)

Chemokines in rheumatoid arthritis: novel, potential therapeutic targets of the CCR2 chemokine receptor signaling pathway
por: Matsushima, K, et al.
Publicado: (2003)

Therapeutic targets for rheumatoid arthritis: lessons from animal models
por: Iwakura, Yoichiro, et al.
Publicado: (2012)

Angiogenesis in rheumatoid arthritis
por: Paleolog, Ewa M
Publicado: (2002)

Hypoxia upregulates angiogenesis and synovial cell migration in rheumatoid arthritis
por: Akhavani, Mohammed A, et al.
Publicado: (2009)

Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis
por: Wunder, A, et al.
Publicado: (2003)

Inflammatory angiogenesis as a target for prevention and therapy: Kaposi's sarcoma and HIV tat as models
por: Albini, Adriana, et al.
Publicado: (2006)

Novel roles for integrins in tumour angiogenesis
por: Germain, M, et al.
Publicado: (2006)

Tax as a therapeutic target in ATL
por: Dassouki, Zeina, et al.
Publicado: (2015)

Juvenile idiopathic arthritis is associated with potentially pathogenic glycosylation of IgG
por: Ercan, Altan, et al.
Publicado: (2012)

The role of Bob1 in rheumatoid arthritis: potential implications for autoimmunity
por: Yeremenko, Nataliya, et al.
Publicado: (2012)

Candidate targets for antibody therapy of rheumatoid arthritis: CD64 and IL-15
por: van de Winkel, J
Publicado: (2003)

Quantitative molecular imaging of angiogenesis-targeted fluorinated nanoparticles: new approaches for B(1)-mapping compensation for (19)F-MRI
por: Goette, Matthew J, et al.
Publicado: (2013)

P122 Myeloid-derived suppressor cells as a potential biomarker and therapeutic target in rhino-orbital mucormycosis patients
por: Singh, Praveen, et al.
Publicado: (2022)

Interleukin-6 as a therapeutic target in locomotor disorders
por: Nishimoto, Norihiro, et al.
Publicado: (2012)

Telomerase: a breast cancer chemopreventive and therapeutic target
por: Shay, JW
Publicado: (2000)

Targeting the glycans of the HIV envelope as a therapeutic tool
por: Balzarini, Jan
Publicado: (2011)

A novel peptide therapeutic targeting PD1 immune checkpoint with equipotent antagonism of both ligands and a potential for better management of immune-related adverse events
por: Sasikumar, Pottayil, et al.
Publicado: (2013)

Cytomics of the tumour microenvironment: therapeutic targeting (keynote lecture)
por: Smith, Paul
Publicado: (2015)

14.6 MRP-Targeting in experimental rheumatoid arthritis allows monitoring of disease activity with optical molecular imaging
por: Eisenblätter, M, et al.
Publicado: (2008)

The αvβ3 integrin as a therapeutic target for inhibition of bone resorption
por: Dixon, SJ, et al.
Publicado: (2004)

Regulation of angiogenesis by angiostatin through immune cells and IL 12 production
por: Noonan, Douglas M, et al.
Publicado: (2006)

Therapeutic targeting truncated adenomatous polyposis coli (APC) proteins for the selective killing of colorectal cancer cells
por: Zhang, Lu, et al.
Publicado: (2014)

Meeting the demands of a podiatry service for patients with arthritis
por: Rome, Keith, et al.
Publicado: (2013)

Activin-A is up-regulated in severe asthma, attenuates allergic responses and is associated with angiogenesis
por: Samitas, Konstantinos, et al.
Publicado: (2013)

Epigenetic modifications of HIV proviral LTRs: potential targets for cure
por: Doerfler, W, et al.
Publicado: (2012)

Probing atherosclerotic angiogenesis with new manganese-based nanocolloid for T1-weighted MRI
por: Wang, Kezheng, et al.
Publicado: (2012)

Prevention of breast tumor angiogenesis and metastasis by cytostatic molecules in relevant mouse models
por: Crépin, M, et al.
Publicado: (2003)

A window on disease pathogenesis and potential therapeutic strategies: molecular imaging for arthritis
por: Gompels, Luke L, et al.
Publicado: (2011)

Proof-of-concept in vivo evaluation of targeted therapeutics: lessons from immunoliposomes
por: Benz, CC
Publicado: (2003)

Envisioning new targets and new approaches for molecular-based cancer therapeutics
por: Tainer, JA
Publicado: (2005)

Proteomics in neurons and animals: substrates and therapeutic potential of alpha-and beta-secretase
por: Lichtenthaler, Stefan
Publicado: (2013)

Markers in rheumatoid arthritis
por: Breedveld, FC
Publicado: (2004)

Mechanisms of pain in arthritis
por: Schaible, H-G
Publicado: (2004)

NF-kappaB inducing kinase (NIK) is a key regulator of inflammation-induced angiogenesis
por: Noort, Ae-Ri, et al.
Publicado: (2012)

The natriuretic peptide/guanylyl cyclase-A system functions as a stress-responsive regulator of angiogenesis in mice
por: Kuhn, Michaela, et al.
Publicado: (2009)

Acute, but not constitutive, loss of endothelial β3-integrin inhibits tumour growth and angiogenesis
por: Steri, Veronica, et al.
Publicado: (2013)

The role of hypoxia in rheumatoid tendon disease
por: Sivakumar, B, et al.
Publicado: (2005)

Calf cramp in children with Charcot-Marie-Tooth disease: searching for therapeutic targets
por: Hawke, Fiona, et al.
Publicado: (2011)

Use of mouse models to validate and therapeutically target transforming growth factor beta as an important player in breast cancer progression
por: Wakefield, LM, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_pkdl86u234nleeh5m9u60k2sk2